251 related articles for article (PubMed ID: 28594755)
1. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.
Rocca CH; Thompson KM; Goodman S; Westhoff CL; Harper CC
Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178
[TBL] [Abstract][Full Text] [Related]
4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
5. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
6. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; McClusky J; Hou MY; Borgatta L
Contraception; 2015 Feb; 91(2):174-7. PubMed ID: 25481376
[TBL] [Abstract][Full Text] [Related]
7. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
8. Contraception after medication abortion in the United States: results from a cluster randomized trial.
Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC
Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072
[TBL] [Abstract][Full Text] [Related]
9. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
10. Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon.
Mayi-Tsonga S; Obiang PA; Minkobame U; Ngouafo D; Ambounda N; de Souza MH
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S45-8. PubMed ID: 24745694
[TBL] [Abstract][Full Text] [Related]
11. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion.
Madden T; Secura GM; Allsworth JE; Peipert JF
Contraception; 2011 Dec; 84(6):571-7. PubMed ID: 22078185
[TBL] [Abstract][Full Text] [Related]
13. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
14. Role of Insurance Coverage in Contraceptive Use After Abortion.
Biggs MA; Taylor D; Upadhyay UD
Obstet Gynecol; 2017 Dec; 130(6):1338-1346. PubMed ID: 29112661
[TBL] [Abstract][Full Text] [Related]
15. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception.
Qasba NT; Stutsman JW; Weaver GE; Jones KE; Daggy JK; Wilkinson TA
J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605
[No Abstract] [Full Text] [Related]
16. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
[TBL] [Abstract][Full Text] [Related]
17. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Varney SJ; Guest JF
Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
[TBL] [Abstract][Full Text] [Related]
18. Impact of long-acting reversible contraception on return for repeat abortion.
Rose SB; Lawton BA
Am J Obstet Gynecol; 2012 Jan; 206(1):37.e1-6. PubMed ID: 21944222
[TBL] [Abstract][Full Text] [Related]
19. Long-acting contraceptive options.
Kaunitz AM
Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
[TBL] [Abstract][Full Text] [Related]
20. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
